Captor Therapeutics SA

Captor Therapeutics SA financial statements

Captor Therapeutics SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenuePLN 4.66MEODHD
Net income−PLN 42MEODHD
Cash and equivalentsPLN 10.72MEODHD
Total debtPLN 3.58MEODHD

Captor Therapeutics SA financials on 6ix · Captor Therapeutics SA on 6ix